MU1742

N/A

Report date: 2023/01/13 14:53:16
NME

Base Information

Drug NameMU1742
Drug Alias NameMU-1742
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCasein kinase I isoform alpha inhibitors
TargetsCasein kinase I isoform alpha
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMasaryk University
China Registration ClassN/A

Develop Information

Active CompaniesMasaryk University
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A